137 related articles for article (PubMed ID: 10957829)
1. Reliability and validity of a self-efficacy instrument specific to sickle cell disease.
Edwards R; Telfair J; Cecil H; Lenoci J
Behav Res Ther; 2000 Sep; 38(9):951-63. PubMed ID: 10957829
[TBL] [Abstract][Full Text] [Related]
2. An assessment of the psychometric properties of the Coping Strategies Questionnaire - Sickle Cell Disease (CSQ-SCD) among adults in the United States.
Salkar M; Rosenthal M; Bhattacharya K; Ramachandran S; Barnard M; Young J; Bentley JP
Health Qual Life Outcomes; 2024 Apr; 22(1):35. PubMed ID: 38644478
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a disease-specific self-efficacy instrument in adolescents with sickle cell disease and its relationship to adjustment.
Clay OJ; Telfair J
Child Neuropsychol; 2007 Mar; 13(2):188-203. PubMed ID: 17364574
[TBL] [Abstract][Full Text] [Related]
4. Outcome results of self-efficacy in children with sickle disease pain who were trained to use guided imagery.
Dobson C
Appl Nurs Res; 2015 Nov; 28(4):384-90. PubMed ID: 26608443
[TBL] [Abstract][Full Text] [Related]
5. Psychometric analysis of the adult sickle cell quality of life measurement information system (ACSQ-Me) in a UK population.
Cooper O; McBain H; Tangayi S; Telfer P; Tsitsikas D; Yardumian A; Mulligan K
Health Qual Life Outcomes; 2019 Apr; 17(1):74. PubMed ID: 31036017
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of SIMS: an instrument for measuring quality of life of adults with sickle cell disease.
Adams-Graves P; Lamar K; Johnson C; Corley P
Am J Hematol; 2008 Jul; 83(7):558-62. PubMed ID: 18161785
[TBL] [Abstract][Full Text] [Related]
7. How patients' self-disclosure about sickle cell pain episodes to significant others relates to living with sickle cell disease.
Derlega VJ; Janda LH; Miranda J; Chen IA; Goodman BM; Smith W
Pain Med; 2014 Sep; 15(9):1496-507. PubMed ID: 25159869
[TBL] [Abstract][Full Text] [Related]
8. Self-efficacy as a predictor of adult adjustment to sickle cell disease: one-year outcomes.
Edwards R; Telfair J; Cecil H; Lenoci J
Psychosom Med; 2001; 63(5):850-8. PubMed ID: 11573035
[TBL] [Abstract][Full Text] [Related]
9. The daily living self-efficacy scale: a new measure for assessing self-efficacy in stroke survivors.
Maujean A; Davis P; Kendall E; Casey L; Loxton N
Disabil Rehabil; 2014; 36(6):504-11. PubMed ID: 23781908
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Korean Version of the Depression Coping Self-Efficacy Scale (DCSES-K).
Lim YM; Perraud S
Arch Psychiatr Nurs; 2016 Aug; 30(4):463-9. PubMed ID: 27455919
[TBL] [Abstract][Full Text] [Related]
11. Depression, disease severity, and sickle cell disease.
Wison Schaeffer JJ; Gil KM; Burchinal M; Kramer KD; Nash KB; Orringer E; Strayhorn D
J Behav Med; 1999 Apr; 22(2):115-26. PubMed ID: 10374138
[TBL] [Abstract][Full Text] [Related]
12. A 2-item short form of the Pain Self-efficacy Questionnaire: development and psychometric evaluation of PSEQ-2.
Nicholas MK; McGuire BE; Asghari A
J Pain; 2015 Feb; 16(2):153-63. PubMed ID: 25463701
[TBL] [Abstract][Full Text] [Related]
13. Spanish version of the self-care self-efficacy scale: A validation study in community-dwelling older adults with chronic multimorbidity.
Chica-Pérez A; Dobarrio-Sanz I; Correa-Casado M; Fernández-Sola C; Ruiz-Fernández MD; Hernández-Padilla JM
Geriatr Nurs; 2023; 53():181-190. PubMed ID: 37540914
[TBL] [Abstract][Full Text] [Related]
14. Psychometrics of the Sickle Cell Disease Health-Related Stigma Scale-Short Form.
Jenerette C; O'Brien J; Jaja C; Carvalho ESS; Brewer C; Hickman RL
West J Nurs Res; 2023 May; 45(5):425-431. PubMed ID: 36495228
[TBL] [Abstract][Full Text] [Related]
15. Development of a sickle cell disease readiness for transition assessment.
Treadwell M; Johnson S; Sisler I; Bitsko M; Gildengorin G; Medina R; Barreda F; Major K; Telfair J; Smith WR
Int J Adolesc Med Health; 2016 May; 28(2):193-201. PubMed ID: 26226115
[TBL] [Abstract][Full Text] [Related]
16. Correlates of hopelessness in clinically stable nigerian adults with sickle cell disease.
Aloba O; Eyiolawi D
Niger J Clin Pract; 2020 Feb; 23(2):219-225. PubMed ID: 32031097
[TBL] [Abstract][Full Text] [Related]
17. Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease.
Sarri G; Bhor M; Abogunrin S; Farmer C; Nandal S; Halloway R; Revicki DA
Health Qual Life Outcomes; 2018 May; 16(1):99. PubMed ID: 29784054
[TBL] [Abstract][Full Text] [Related]
18. A Dutch version of the Overall Anxiety Severity and Impairment Scale (OASIS): Psychometric properties and validation.
Hermans M; Korrelboom K; Visser S
J Affect Disord; 2015 Feb; 172():127-32. PubMed ID: 25451406
[TBL] [Abstract][Full Text] [Related]
19. Development and psychometric testing of the relocation self-efficacy scale.
Rossen EK; Gruber KJ
Nurs Res; 2007; 56(4):244-51. PubMed ID: 17625463
[TBL] [Abstract][Full Text] [Related]
20. Self-efficacy and readiness for transition from pediatric to adult care in sickle cell disease.
Treadwell M; Johnson S; Sisler I; Bitsko M; Gildengorin G; Medina R; Barreda F; Major K; Telfair J; Smith WR
Int J Adolesc Med Health; 2016 Nov; 28(4):381-388. PubMed ID: 26226116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
